RECOVERY & TISSUE REPAIR / FAQ
Common Questions, Honest Answers
Straight, citation-anchored answers to the questions readers bring most often to these four repair peptides.
What does BPC-157 do in the body?
In animal models, BPC-157 is described as a cytoprotective and regenerative peptide. Its repair effects are tied most consistently to angiogenesis — encouraging new blood-vessel growth into injured tissue by making vascular endothelial cells more responsive to the VEGFR2 vessel-growth signal [4]. It has accelerated healing in rat models of gastric ulcers [5]. It is also described as modulating brain-gut signaling pathways. Crucially, almost all of this is preclinical; human evidence is limited to three small pilot studies [2].
Is BPC-157 a growth hormone?
No. BPC-157 is not a growth hormone and is not growth hormone in any form. It is a synthetic fifteen-amino-acid peptide derived from a protein in gastric juice. There is a connection point that sometimes causes confusion: in tendon cells, BPC-157 has been reported to sensitize the growth-hormone receptor, which may amplify the body's own growth hormone signal. Making a receptor more responsive to something is not the same as being that something. BPC-157 does not substitute for or act as growth hormone.
Does BPC-157 work immediately, and how long does it stay in the body?
The peptide clears from the bloodstream quickly. Pharmacokinetic work in rats and dogs found an elimination half-life under 30 minutes and rapid breakdown into fragments that re-enter normal amino-acid metabolism [3]. A short half-life means the intact molecule does not linger long after dosing. Whether a healing effect appears quickly is a separate question — the published healing data come from animal studies measured over days to weeks [5]. This site does not advise on use or timing.
Does BPC-157 damage the liver?
The available data do not show liver harm, but those data are very thin. In the 2025 first-in-human intravenous safety pilot, BPC-157 up to 20 mg in two healthy adults produced no measurable changes in hepatic, cardiac, renal, thyroid, or glucose biomarkers, and no adverse events [1]. That is reassuring, but it is two people in a safety pilot. A 2025 review emphasizes that without long-term, large-sample human data, the overall safety profile remains genuinely unknown [2]. Nothing here is medical advice.
What is TB-500, and what does "TB" stand for?
"TB" refers to thymosin beta — specifically thymosin beta-4 (Tβ4), the natural protein that TB-500's sequence is drawn from. TB-500 is a synthetic seven-amino-acid fragment, Ac-LKKTETQ, corresponding to the actin-binding region (residues 17–23) of thymosin beta-4 [10]. The key nuance: in commerce and anti-doping science, "TB-500" means that short fragment, but most published effectiveness research used the full-length Tβ4 protein, which is about five times heavier [8]. The name points at a fragment while much of its reputation rests on the whole protein.
What is TB-500 used for in research?
In research, TB-500 and full-length thymosin beta-4 are studied for tissue repair via actin regulation: cell migration, new blood-vessel growth, reduced scarring, and anti-inflammatory signaling, across models in dermal wounds, cornea, heart, and CNS [8]. A human Phase 1 study of full-length Tβ4 in 40 volunteers focused on safety and pharmacokinetics [9], and a rat stroke study examined neurological recovery [7]. There are no completed controlled clinical trials of the TB-500 fragment itself for any indication [6].
Does TB-500 work for muscle tears and recovery from exercise?
There is no controlled human evidence that the TB-500 fragment helps muscle tears or exercise recovery. The mechanistic rationale comes from thymosin beta-4's role in cell migration and actin-mediated repair [8], but a 2026 Sports Medicine review of unapproved peptides for musculoskeletal injury concluded that favorable animal results have not been matched by rigorous human safety or efficacy data, and that these compounds operate largely outside regulatory oversight [6]. Notably, in a muscular-dystrophy mouse model chronic Tβ4 increased regenerating fibers but did not improve muscle strength [8]. TB-500 is also banned in sport [6].
What does a GHK-Cu peptide do, and how does it work?
GHK-Cu is a copper-carrying tripeptide that signals repair and delivers copper simultaneously. At very low concentrations it tells dermal fibroblasts to synthesize collagen, elastin, glycosaminoglycans, and decorin, while rebalancing matrix-degrading enzymes against their inhibitors; the copper enables collagen and elastin cross-linking and an antioxidant action [16]. At the gene level it shifts expression of roughly 31.2% of human genes toward repair, DNA-repair, and antioxidant programs [14]. Most of its documented human benefit is from topical skin applications [13].
Is GHK-Cu really anti-aging?
There is real human evidence for skin benefits, though it is modest and mostly topical. GHK-Cu increased collagen production in about 70% of treated women — outperforming vitamin C (50%) and retinoic acid (40%) — and reviews document placebo-controlled improvements in skin laxity, fine lines, and wrinkle depth [16]. Two honest caveats belong with that: the widely quoted "~4,000 genes" figure is an extrapolation from a verified count of roughly 2,100 genes at the measured threshold [14], and the peptide crosses intact skin poorly, limiting how much reaches the dermis without delivery aids [13]. Systemic "anti-aging" use is unproven.
What is the difference between GHK and GHK-Cu?
GHK is the bare tripeptide glycyl-histidyl-lysine; GHK-Cu is that same tripeptide chelated to a copper(II) ion. The distinction is functional, not cosmetic — copper coordination is required for most of GHK's reported bioactivities, and the two are frequently conflated in secondary sources [16]. In practice, when studies describe collagen stimulation, cross-linking, and antioxidant effects, it is generally the copper complex (GHK-Cu) performing those functions.
What is KPV peptide, and what is it used for?
KPV is a three-amino-acid peptide (Lys-Pro-Val) that is the tail end of the hormone alpha-MSH. In research it is studied as an anti-inflammatory agent: it suppresses NF-kB and MAP-kinase signaling and lowers pro-inflammatory cytokines [20], while retaining none of the parent hormone's pigment-producing effect [22]. Its most-studied application is in mouse models of gut inflammation (colitis), where it has reduced disease severity and accelerated mucosal healing [21]. There are no human clinical trials of KPV [20].
What is KPV peptide good for, according to the research?
The research signal is strongest for calming inflammation, especially in the gut. KPV reduced colonic inflammation, sped recovery, and lowered inflammatory markers in mouse colitis [21], and targeted-delivery formulations carrying KPV to inflamed colon tissue outperformed non-targeted versions [19][18]. A broad review also notes anti-inflammatory and protective effects of alpha-MSH-derived tripeptides across skin, eye, airway, joint, and organ-injury models [22]. All of this is preclinical; KPV is not an approved treatment for any condition [20].